Amyloid β1-42 peptide alters the gating of human and mouse α-bungarotoxin-sensitive nicotinic receptors

Journal of Physiology

Volumn 547, Issue 1, 2003, Pages 147-157

  Grassi, Francesca ^a,b   Palma, Eleonora ^a,b   Tonini, Raffaella ^a,b   Amici, Mascia ^a   Ballivet, Marc ^c   Eusebi, Fabrizio ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Dipartimento di Scienze Internistiche   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN; GLUTAMIC ACID; GLYCINE; METHYLLYCACONITINE; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; ACETYLCHOLINE; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[40-1]; AMYLOID BETA PROTEIN[42-1]; BUNGAROTOXIN RECEPTOR; GLYCOPROTEIN; MUTANT PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; BINDING AFFINITY; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; EVOKED RESPONSE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; VOLTAGE CLAMP; XENOPUS; ADULT; ARTICLE; DEGENERATIVE DISEASE; FEMALE; FETUS; MEMBRANE CONDUCTANCE; MEMBRANE CURRENT; MUSCLE; MUSCLE DISEASE; VOLTAGE CLAMP TECHNIQUE; WILD TYPE;

EID: 0037440717     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.035436     Document Type: Article

References (39)

1. Askanas V & Engel WK (1998). Does overexpression of β APP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Am J Pathol 153, 1673-1677.
2. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM & Sweatt JD (1998). The MAPK cascade is required for mammalian associative learning. Nature Neurosci 1, 602-609.
3. Coles M, Bicknell W, Watson AA, Fairlie DP & Craik DJ (1998) Solution structure of amyloid β-peptide(1-40) in a water-micelle environment. Is the membrane spanning domain where we think it is? Biochemistry 37, 11064-11077.
4. Dineley KT, Bell K, Bui D & Sweatt JD (2002). β-Amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 277, 25056-25061.
5. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH & Sweatt JD (2001). β-Amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 21, 4125-4133.
6. Fucile S, Mileo AM, Grassi F, Salvatore AM, Alemà S & Eusebi F (1996). Identification of a determinant of AChR gating kinetics in the extracellular portion of the γ subunit. Eur J Neurosci 8, 2564-2570.
7. Fucile S, Palma E, Eusebi F & Miledi R (2002). Serotonin antagonizes the human neuronal α7 nicotinic acetylcholine receptor and becomes an agonist after L248T α7 mutation. Neuroscience 110, 169-179.
8. 2+ permeable. Proc Natl Acad Sci U S A 97, 3643-3648.
9. Giordano T, Pan JB, Monteggia LM, Holzman TF, Snyder SW, Krafft G, Ghanbari H & Kowall NW (1994). Similarities between beta amyloid peptides 1-40 and 40-1: effects of aggregation, toxicity in vitro, and injection in young and aged rats. Exp Neurol 125, 175-182.
10. Grassi F (1999). 5-Hydroxytryptamine blocks the fetal more potently than the adult mouse muscle acetylcholine receptor. Pflugers Arch 437, 903-909.
11. Guan ZZ, Zhang X, Ravid R & Nordberg A (2000). Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74, 237-243.
12. Kuo Y-M, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR & Roher AE (2000a). Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun 268, 750-756.
13. Kuo Y-M, Kokjohn TA, Watson DM, Woods AS, Cotter RJ, Sue LI, Kalback W, Emmerling MR, Beach TG & Roher AE (2000b). Elevated Aβ 42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of Aβ PP metabolism. Am J Pathol 156, 797-805.
14. Kullberg R, Owens JL, Camacho P, Mandel G & Brehm P (1990). Multiple conductance classes of mouse nicotinic acetylcholine receptors expressed in Xenopus oocytes. Proc Natl Acad Sci U S A 87, 2067-2071.
15. Liou YJ, Lai IC, Hong CJ, Liu HC, Liu TY & Tsai SJ (2001). Association analysis of the partially duplicated α7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease. Dement Geriatr Cogn Disord 12, 301-304.
16. Liu Q-S, Kawai H & Berg DK (2001). β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A 98, 4734-4739.
17. Maggi L, Palma E, Eusebi F, Moretti M, Balestra B, Clementi F & Gotti CG (1999). Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick α7 nicotinic receptor. Br J Pharmacol 126, 285-295.
18. Mehta PD, Pirttilä T, Mehta SP, Sersen EA, Aisen PS & Wisniewski HM (2000). Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57, 100-105.
19. Methfessel C, Witzemann V, Takahashi T, Mishina M, Numa S & Sakmann B (1986). Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pflugers Arch 407, 577-588.
20. Miledi R, Eusebi F, Martinez-Torres A, Palma E & Trettel F (2002). Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes. Proc Natl Acad Sci U S A 99, 13238-13242.
21. Moechars D, Dewachter I, Lorent K, Reversé D, Baekelt V, Naidu A, Tesseur I, Spittaels K, Van Den Haute C, Checler F, Godaux E, Cordell B & Van Leuven F (1999). Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274, 6483-6492.
22. Nagele RG, D'Andrea MR, Anderson WJ & Wang H-Y (2002). Intracellular accumulation of β-amyloid, in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199-211.
23. Neve RL & Robakis NK (1998). Alzheimer's disease: a reexamination of the amyloid hypothesis. Trends Neurosci 21, 15-19.
24. Nordberg A (2001). Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol Psychiatry 49, 200-210.
25. Palma E, Fucile S, Barabino B, Miledi R & Eusebi F (1999). Strychnine activates neuronal α7 nicotinic receptors after mutations in the leucine ring and transmitter binding site domains. Proc Natl Acad Sci U S A 96, 13421-13426.
26. Palma E, Maggi L, Eusebi F & Miledi R (1997). Neuronal nicotinic threonine-for-leucine 247 α7 mutant receptors show different gating kinetics when activated by acetylcholine or by the noncompetitive agonist 5-hydroxytryptamine. Proc Natl Acad Sci U S A 94, 9915-9919.
27. 2+ on wild and mutant neuronal α7 nicotinic receptors. Proc Natl Acad Sci U S A 95, 10246-10250.
28. Palma E, Mileo AM, Eusebi F & Miledi R (1996). Threonine-for-leucine mutation within domain M2 of the neuronal α7 nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Proc Natl Acad Sci U S A 93, 11231-11235.
29. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21, RC120 1-5.
30. Revah F, Bertrand D, Galzi JL, Devillers-Thiery A, Mulle C, Hussy N, Bertrand S, Ballivet M & Changeux JP (1991). Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature 353, 846-849.
31. Selkoe DJ (1994). Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17, 489-517.
32. Selkoe DJ (2001). Alzheimer's disease: genes, proteins and therapy. Physiol Rev 81, 741-766.
33. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN & Li WY (1994). Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45, 373-379.
34. Smith DA (2002). Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci U S A 99, 4135-4137.
35. Sugarman MC, Yamasaki TR, Oddo S, Echegoyen JC, Murphy MP, Golde TE, Jannatipour M, Leissring MA, Laferla FM (2002). Inclusion body myositis-like phenotype induced by transgenic overexpression of β APP in skeletal muscle. Proc Natl Acad Sci USA 99, 6334-6339.
36. Tozaki H, Matsumoto A, Kanno T, Nagai K, Nagata T, Yamamoto S, Nishizaki T (2002). The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors. Biochem Biophys Res Commun 294, 42-45.
37. Wang H-Y, D'Andrea MR & Nagele RG (2002). Cerebellar diffuse amyloid plaques are derived from dendritic Aβ 42 accumulation of Purkinje cells. Neurobiol Aging 23, 213-223.
38. 1-42 binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275, 5626-5632.
39. 1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors. J Neurochem 75, 1155-61.